JP Morgan Raises MRSH Price Target to $218

JP Morgan reaffirmed its Overweight rating on Marsh & McLennan Companies, Inc. (NYSE: MRSH) and lifted its price target to $218 from $215 on October 20, 2026. The firm issued its research note on the same day the insurance broker's stock closed at $190.28.

MRSH Marsh & McLennan Companies, Inc.

$190.48 ▲ +6.68% year to date

1M 3M YTD

Daily close · Oct 20, 2026

JP Morgan's Call on Marsh & McLennan

In its October 20, 2026 research note, JP Morgan kept its Overweight rating on the insurance broker while adjusting the price target upward from $215. The move puts the firm's target above the general Wall Street consensus, as other institutions actively update their models on the company.

Other Institutional Activity in Marsh & McLennan

Capital International Investors grew its holdings by 15,714 shares, ending with 15,729,457 shares worth about $2.99 billion in its report filed for the period ended June 30, 2026.

Marsh & McLennan Companies, Inc. Stock Up 0.9%

The company's shares recently traded around $190.12 as of October 20, 2026. That level sits roughly 4.9% above its 50-day moving average of $181.22 and about 7.6% above its 200-day moving average of $176.72. The stock has traded between a 52-week low of $156.60 and a 52-week high of $198.49.

Recent Earnings

Marsh & McLennan generated $28.46 billion in trailing twelve-month revenue and posted earnings of $8.36 per share over the same period. The firm recorded a net profit margin of 14.2% and a return on equity of 27.2%. The company's next earnings report is scheduled for release on January 28, 2027.

Dividend

The company pays an annual dividend rate of $3.96 per share, giving it a dividend yield of 2.1%. The payout is supported by a dividend payout ratio of 44.1% based on recent earnings.

Insider Buying and Selling at Marsh & McLennan Companies, Inc.

Chief Technology Officer Paul Beswick sold 713 shares at $198.00 for $141,174 on July 29, 2026. Officer John Jude Jones sold 6,500 shares at $191.96 for nearly $1.25 million on August 6, 2026. General Counsel Katherine J. Brennan sold 1,197 shares at $187.90 for $224,915 on September 2, 2026. Chief Executive Officer John Q. Doyle sold 16,656 shares at $188.51 for $3.14 million on September 2, 2026.

Analysts Set New Price Targets

Citigroup maintained its Neutral rating on the stock while raising its price target to $203.00 from $200.00 on October 16, 2026. Wells Fargo maintained its Equal-Weight rating and lifted its target to $197.00 from $183.00 on October 16, 2026. Mizuho maintained a Neutral rating and moved its target to $200.00 from $190.00 on October 19, 2026. Keefe, Bruyette & Woods maintained a Market Perform rating while raising its target to $201.00 from $186.00 on October 19, 2026. Overall, the stock carries a consensus hold rating across 21 analyst opinions with a mean price target of $205.38.

About Marsh & McLennan

Marsh & McLennan Companies, Inc. is a professional services firm headquartered in New York City that provides risk management, insurance brokerage, and consulting solutions to corporate clients worldwide through various specialized operating units. The firm operates across multiple continents, helping businesses navigate complex risk environments and employee benefit structures.

Bottom Line

Investors will look toward the company's next earnings release on January 28, 2027, to see how advisory and insurance brokerage revenues hold up. JP Morgan's updated target highlights ongoing institutional attention as the stock trades near the upper end of its 52-week range.